CRF test in melancholic depressive patients with partial versus complete relapses: A 2-year follow-up study

References

• Chrousos GP, Calabrese JR, Avgerinos P, Kling MA, Rubinow D, Oldfield EH, et al. Corticotropin releasing factor: Basis studies and clinical applications. Prog Neuro-Psychopharmacol Biol Psychiatry 1988;9:349–59.
   Google Scholar
• Pintor L, Torres X, Navarro V, Martinez de Osaba MJ, Matrai S, Gastó C. Corticotropin-releasing factor test in melancholic patients in depressed state versus recovery: A comparative study. Prog NeuroPsychopharmacol Biol Psychiatry 2007;31:1027–33.
   PubMed Web of Science ®Google Scholar
• Pintor L, Torres X, Navarro V, Martinez de Osaba MJ, Matrai S, Gastó C. Prediction of relapse in melancholic depressive patients in a 2-year follow-up study with corticotropin-releasing factor test. Prog NeuroPsychopharmacol Biol Psychiatry 2009;33: 463–69.
   PubMed Web of Science ®Google Scholar
• Van Den Eede F, Van den Bossche B, Hulstijn W, Sabbe BGC, Cosyns P, Claes SJ. Combined dexamethasone/CRF test in remitted outpatients with recurrent major depressive disorder. J Affect Disord 2006;93:259–63.
   PubMed Web of Science ®Google Scholar
• Appelhof BC, Huyser J, Vermeij M, Brouwer JP, Van Dick R, Fliers E, et al. Glucocorticoids and relapse of major depression (dexamethasone/corticotropin-releasing hormone test in relation to relapse of major depression). Biol Psychiatry 2006;59:696–701.
   PubMed Web of Science ®Google Scholar
• Aubry JM, Gervasoni N, Osiek Ch, Perret G, Rossier MF, Bertschy G, et al. The DEX/CRH neuroendocrine test and prediction of depressive relapse in remitted depressed outpatients. J Psychiatric Research 2007;41:290–94.
   PubMed Web of Science ®Google Scholar
• Pintor L, Torres X, Navarro V, Matrai S, Gastó C. Is the type of remission after a major depressive episode an important risk factor to relapses in a 4-year follow-up? J Affect Disord 2004; 82:291–96.
   PubMed Web of Science ®Google Scholar
• First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV axis I disorders—Clinician version (SCID-CV), American Psychiatry Association Press, Washington DC and London;1997 (Spanish version, Masson SA, 1999).
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edition. Washington, DC: American Psychiatric Press; 1994.
   Google Scholar
• Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56–62.
   PubMed Web of Science ®Google Scholar
• Bech P, Rafaelsen OJ. The use of rating scales exemplified by a comparison of the Hamilton and the Bech Rafaelsen Melancholia Scale. Act Psychiatr Scand 1980;62 Suppl 185:128–32.
   Google Scholar
• Carney MWP, Sheffield BF. Depression and the Newcastle scales: Their relationship to Hamilton's scale. Br J Psychiatry 1972; 121:35–40.
   PubMed Web of Science ®Google Scholar
• Maes M, Claes M, Vandewoude M, Schotte C, Martin M, Blockx P, et al. ACTH, beta-endorphin and cortisol responses to oCRH in melancholic patients. Psychol Med 1992;22:317–29.
   PubMed Web of Science ®Google Scholar
• Frank E, Prien RF, Jarret RB, Keller MB, Kupfer DJ, Lavori PW, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder: Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 1991;48:851–55.
   PubMed Web of Science ®Google Scholar
• Demidovich BP, Maron IA. Cálculo numérico fundamental (Segunda edición). Madrid: Paraninfo; 1985.
   Google Scholar
• Rybakowski JK, Twardowska K. The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness. J Psychiatr Res 1999;33: 363–70.
   PubMed Web of Science ®Google Scholar
• Posener JA, DeBattista CH, Williams GH. 24-hour monitoring of cortisol and coricotropin secretion in psychotic and nonpsychotic major depression. Arch Gen Psychiatry 2000;57:755–60.
   PubMed Web of Science ®Google Scholar
• Herbert J, Goodyer IM, Grossman AB, Hastings MH, de Kloet ER, Lightman SL, et al. Do corticosteroids damage the brain? J Neuroendocrinol 2006;18:393–411.
   PubMed Web of Science ®Google Scholar
• McKinnon MC, Yucel K, Nazarov A, MacQueen GM. A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder. J Psychiatry Neurosci 2009;34:41–54.
   PubMed Web of Science ®Google Scholar
• Post RM. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 1992;149: 999–1010.
   PubMed Web of Science ®Google Scholar
• Dinan TG. Glucocorticoids and the genesis of depressive illness. A psychobiological model. Br J Psychiatry 1994;164: 365–71.
   PubMed Web of Science ®Google Scholar
• Künzel HE, Binder EB, Nickel T, Ising M, Fuchs B, Majer M, et al. Pharmacological and nonpharmacological factors influencing hypothalamic–pituitary–adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex–CRH test. Neuropsychopharmacology 2003;28:2169–78.
   PubMed Web of Science ®Google Scholar
• Handwerger K. Differential patterns of HPA activity and reactivity in adult posttraumatic stress disorder and major depressive disorder. Harv Rev Psychiatry 2009;17:184–205.
   PubMed Web of Science ®Google Scholar
• Zobel AW, Nickel T, Sonntag A, Uhr M, Holsboer F, Ising M. Cortisol response in the combined dexamethasone–CRH test as predictor of relapse in patients with remitted depression: A prospective study. J Psychiatr Research 2001;35:83–94.
   PubMed Web of Science ®Google Scholar
• Rickels K, Schweizer E. Clinical overview of serotonin reuptake inhibitors. J Clin Psychiatry 1990;51(12 Suppl B):9–12.
   PubMedGoogle Scholar
• Workman EA, Short DD. Atypical antidepressants versus imipramine in treatment of major depression: A meta-analysis. J Clin Psychiatry 1993;54:5–12.
   PubMed Web of Science ®Google Scholar
• Amsterdam JD, Maislin G, Winokur A, Kling M, Gold PW. Pituitary and adrenocortical responses to the ovine corticotropin-releasing hormone stimulation test. Arch Gen Psychiatry 1987;44: 775–81.
   PubMed Web of Science ®Google Scholar
• Heuser IJ, Schweiger U, Gotthardt U, Schmider J, Lammers CH, Dettling M, et al. Pituitary–adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects. Am J Psychiatry 1996;153:93–99.
   PubMed Web of Science ®Google Scholar
• Stokes PE, Stoll PM, Koslow SH, Maas JW, Davis JM, Swann AC, et al. Pretreatment DST and hypothalamic–pituitary.adrenocortical function in depressed patients and comparison groups: A multi-center study. Arch Gen Psychiatry 1984;41:257–67.
   PubMed Web of Science ®Google Scholar
• Heuser I, Wark HJ, Keul J, Holsboer F. Altered pituitary– adrenocortical function in elderly endurance athletes. J Clin Endocrinol Metab 1991;73:485–88.
   PubMed Web of Science ®Google Scholar
• Seeman TE, Singer B, Charpentier P. Gender differences in patterns of HPA axis response to challenge: MacArthur studies of successful aging. Psychoneuroendocrinology 1995;20:711–25.
   PubMed Web of Science ®Google Scholar